Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
This study investigated whether children with autism spectrum disorders (ASDs) exhibit formal thought disorder (FTD), and whether this is related to ASD symptoms, executive control, and anxiety. Participants aged 8-17 with ASDs exhibited significantly more illogical thinking and loose associations than matched typically developing control subjects. In participants with ASDs, illogical thinking was related to aspects of cognitive functioning and to executive control. Loose associations were related to autism communication symptoms and to parent reports of stress and anxiety. When FTD is present in ASDs, it generally is not a co-morbid schizophrenia symptom, but is related to pragmatic language abnormalities found in ASDs. The clinical and neurobiological significance of this work is discussed. KeywordsAutism spectrum disorders; Schizophrenia; Thought disorder; Executive functions; Anxiety Autism and schizophrenia are heterogeneous disorders with presentations that vary across severity-graded spectra. There has been longstanding interest in understanding the Correspondence to: Marjorie Solomon. HHS Public AccessAuthor manuscript J Autism Dev Disord. Author manuscript; available in PMC 2017 July 20. Author Manuscript Author ManuscriptAuthor ManuscriptAuthor Manuscript relationship between these two disorders. Initially, it was believed that autism was the earliest manifestation of schizophrenia, which then presented fully in late adolescence or early adulthood (Bender 1947). Later, Kolvin (1971) and Rutter (1972) suggested the two disorders were functionally distinct, and empirical research demonstrated that individuals diagnosed with autism did not develop schizophrenia at a rate higher than the general population (Mouridsen et al. 1999;Sporn et al. 2004;Volkmar and Cohen 1991).More recently, it has been proposed that the presence of an autism spectrum disorder (ASD), including high functioning autism, Asperger's Disorder, and Pervasive Developmental Disorder Not Otherwise Specified (PDDNOS), may be a nonspecific marker of severe early abnormal neurodevelopment present in disorders including schizophrenia. Consistent with this view, multiple studies have documented premorbid childhood social difficulties and oddness in individuals later diagnosed with schizophrenia (Schiffman et al. 2004;Walker et al. 1993);and Sporn et al. (2004) found that ASD was present in 25% of a cohort of children diagnosed with early onset schizophrenia.Developing a better understanding of differences between the autism and schizophrenia is important both clinically and scientifically. For clinicians, early accurate diagnosis of both disorders is imperative given its association with improved language and social functioning in autism (Ozonoff et al. 2007) and the relationship between untreated illness duration and poor outcome in schizophrenia (Keshavan and Amirsadri 2007). Differential diagnosis of schizophrenia and ASDs can be challenging, however, because symptoms may be difficult to distinguish or even overlap (Sheitman et al...
This study investigated whether children with autism spectrum disorders (ASDs) exhibit formal thought disorder (FTD), and whether this is related to ASD symptoms, executive control, and anxiety. Participants aged 8-17 with ASDs exhibited significantly more illogical thinking and loose associations than matched typically developing control subjects. In participants with ASDs, illogical thinking was related to aspects of cognitive functioning and to executive control. Loose associations were related to autism communication symptoms and to parent reports of stress and anxiety. When FTD is present in ASDs, it generally is not a co-morbid schizophrenia symptom, but is related to pragmatic language abnormalities found in ASDs. The clinical and neurobiological significance of this work is discussed. KeywordsAutism spectrum disorders; Schizophrenia; Thought disorder; Executive functions; Anxiety Autism and schizophrenia are heterogeneous disorders with presentations that vary across severity-graded spectra. There has been longstanding interest in understanding the Correspondence to: Marjorie Solomon. HHS Public AccessAuthor manuscript J Autism Dev Disord. Author manuscript; available in PMC 2017 July 20. Author Manuscript Author ManuscriptAuthor ManuscriptAuthor Manuscript relationship between these two disorders. Initially, it was believed that autism was the earliest manifestation of schizophrenia, which then presented fully in late adolescence or early adulthood (Bender 1947). Later, Kolvin (1971) and Rutter (1972) suggested the two disorders were functionally distinct, and empirical research demonstrated that individuals diagnosed with autism did not develop schizophrenia at a rate higher than the general population (Mouridsen et al. 1999;Sporn et al. 2004;Volkmar and Cohen 1991).More recently, it has been proposed that the presence of an autism spectrum disorder (ASD), including high functioning autism, Asperger's Disorder, and Pervasive Developmental Disorder Not Otherwise Specified (PDDNOS), may be a nonspecific marker of severe early abnormal neurodevelopment present in disorders including schizophrenia. Consistent with this view, multiple studies have documented premorbid childhood social difficulties and oddness in individuals later diagnosed with schizophrenia (Schiffman et al. 2004;Walker et al. 1993);and Sporn et al. (2004) found that ASD was present in 25% of a cohort of children diagnosed with early onset schizophrenia.Developing a better understanding of differences between the autism and schizophrenia is important both clinically and scientifically. For clinicians, early accurate diagnosis of both disorders is imperative given its association with improved language and social functioning in autism (Ozonoff et al. 2007) and the relationship between untreated illness duration and poor outcome in schizophrenia (Keshavan and Amirsadri 2007). Differential diagnosis of schizophrenia and ASDs can be challenging, however, because symptoms may be difficult to distinguish or even overlap (Sheitman et al...
Background The clinical and etiological relation between autism spectrum disorders (ASD) and schizophrenia is unclear. The degree to which these disorders share a basis in etiology has important implications for clinicians, researchers, and those affected. Our objective was to determine if a family history of schizophrenia and/or bipolar disorder was a risk factor for ASD. We conducted a case-control evaluation of histories of schizophrenia or bipolar disorder in first-degree relatives of probands in three samples, population registers in Sweden, Stockholm County, and Israel. Probands met criteria for ASD, and affection status of parents and siblings for schizophrenia and bipolar disorder were established. Findings The presence of schizophrenia in parents was associated with an increased risk for ASD in a Swedish national cohort (odds ratio 2.9, 95% CI 2.5–3.4) and in a Stockholm County cohort (odds ratio 2.9, 95% CI 2.0–4.1). Similarly, schizophrenia in a sibling was associated with an increased risk for ASD in a Swedish national cohort (odds ratio 2.6, 95% CI 2.0–3.2) and in an Israeli conscription cohort (odds ratio 12.1, 95% CI 4.5–32). Bipolar disorder showed a similar pattern of associations but of lesser magnitude. Interpretation Findings from these three registers along with consistent findings from a similar study in Denmark suggest that ASD, schizophrenia, and bipolar disorder share common etiological factors. Funding Swedish Council for Working Life and Social Research, the Swedish Research Council, and the Beatrice and Samuel A. Seaver Foundation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.